Giulia Petroni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Endoplasmic Reticulum

Radiation Induced

Top Venues

Journal of translational medicine

Cancer research

Nature reviews. Drug discovery

Molecular & cellular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy. Cancer research (2024)
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer research 84 (8) (2024)
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C Formenti, Lorenzo Galluzzi, Giulia Petroni
Cellular senescence in the response of HR + breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine 21 (1) (2023)
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C Formenti, Lorenzo Galluzzi, Giulia Petroni
Cellular senescence in the response of HR + breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine 21 (1) (2023)
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C Formenti, Lorenzo Galluzzi, Giulia Petroni
Cellular senescence in the response of HR + breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine 21 (1) (2023)
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C Formenti, Lorenzo Galluzzi, Giulia Petroni
Cellular senescence in the response of HR + breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine 21 (1) (2023)
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C Formenti, Lorenzo Galluzzi, Giulia Petroni
Cellular senescence in the response of HR + breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine 21 (1) (2023)
Giulia Petroni, Aitziber Buqué, Lisa M Coussens, Lorenzo Galluzzi
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nature reviews. Drug discovery 21 (6) (2022)
Giulia Petroni, Aitziber Buque, Takahiro Yamazaki, Norma Bloy, Maurizio Di Liberto, Selina Chen-Kiang, Sylvia C Formenti, Lorenzo Galluzzi
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2021)
Giulia Petroni
Targeting potassium channels and autophagy to defeat chemoresistance. Molecular & cellular oncology 7 (3) (2020)
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buque, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro-Manzano, Francisco Ayala, Elena García-Martínez, Sylvia C Formenti, Zlatko Trajanoski, Lorenzo Galluzzi
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology 21 (10) (2020)